A synthetic heptapeptide analog of tuftsin, approved in Russia as an anxiolytic and studied for its nootropic and immunomodulatory properties.
Selank is a seven-amino-acid synthetic peptide built on tuftsin, a natural immune-modulating peptide in your body. Russian scientists at the Institute of Molecular Genetics added a Pro-Gly-Pro tail that dramatically extends its stability and half-life. Russia approved it in 2009 as a nasal spray for generalized anxiety and cognitive enhancement.
The anxiolytic mechanism of Selank involves modulation of the GABAergic system and monoamine neurotransmitter pathways. Research has shown that Selank increases BDNF (brain-derived neurotrophic factor) expression in the hippocampus, modulates the balance of T-helper 1 and T-helper 2 cytokines, influences serotonin metabolism by affecting tryptophan hydroxylase expression, and stabilizes enkephalin levels in the blood [2]. Unlike benzos, Selank doesn't sedate you, fog your thinking, or create dependence. That's a huge differentiator.
On the cognitive side, animal studies show Selank improves learning and memory — especially when stress would normally impair those functions. Gene expression studies reveal that Selank affects the expression of 36 genes in the hippocampus, many related to neuronal plasticity, signal transduction, and neurotransmitter regulation [3]. The compound also exhibits significant immunomodulatory activity, influencing IL-6, TNF-alpha, and interferon expression, reflecting its tuftsin-derived heritage.
Selank's anxiolytic and nootropic effects arise from a multifaceted interaction with several neurochemical systems, distinct from conventional anxiolytics:
Selank modulates the GABAergic system without directly binding to GABA-A receptors in the manner of benzodiazepines. Instead, it influences GABA metabolism and receptor sensitivity, producing anxiolytic effects without the sedation, tolerance, or withdrawal associated with direct GABA-A agonists. This mechanism makes Selank functionally anxiolytic while preserving alertness and cognitive function [1].
Selank upregulates BDNF expression in the hippocampus and prefrontal cortex. BDNF is a key mediator of synaptic plasticity, long-term potentiation, and neuronal survival. Increased BDNF levels are associated with improved learning, memory consolidation, and resilience to stress-induced neuronal damage. This mechanism likely underlies Selank's nootropic properties [3].
Research demonstrates that Selank influences serotonin metabolism through modulation of tryptophan hydroxylase expression, the rate-limiting enzyme in serotonin synthesis. Additionally, Selank stabilizes enkephalin levels in the blood, preventing their rapid enzymatic degradation. Enkephalins are endogenous opioid peptides involved in mood regulation and stress adaptation. This dual action on serotonergic and opioidergic systems contributes to the compound's anxiolytic profile.
Reflecting its tuftsin heritage, Selank modulates immune function through effects on cytokine expression. It has been shown to influence the balance of pro-inflammatory (Th1) and anti-inflammatory (Th2) cytokines, normalize IL-6 and TNF-alpha levels, and enhance antiviral interferon expression [4]. These immunomodulatory effects operate independently of the anxiolytic mechanism and may contribute to improved well-being during periods of psychological stress.
Selank can be administered intranasally or subcutaneously. The intranasal route is most commonly used in approved Russian clinical practice and provides rapid absorption through the nasal mucosa.
| Protocol | Dose | Frequency | Duration | Notes |
|---|---|---|---|---|
| Intranasal (standard) | 250–500 mcg | 2–3x daily | 14–21 days | Most common research route; rapid absorption |
| Subcutaneous | 250–500 mcg | Once daily | 14–21 days | Higher bioavailability than intranasal |
| Low-dose anxiolytic | 250 mcg | 2x daily (intranasal) | 14 days | Conservative starting protocol |
| Nootropic focus | 500 mcg | 2–3x daily (intranasal) | 21 days | Higher dose for cognitive enhancement |
Reconstitute the Selank with bacteriostatic water. The Pro-Gly-Pro extension provides better stability than native tuftsin. For intranasal use, the reconstituted solution is transferred to a nasal spray device.
2 mL of bacteriostatic water into a sterile syringe. For a 5 mg vial, this yields a concentration of 2,500 mcg/mL.5 mg vial + 2 mL BAC water: Concentration = 2,500 mcg/mL
250 mcg dose = 10 units (0.1 mL) on a 100-unit insulin syringe
500 mcg dose = 20 units (0.2 mL) on a 100-unit insulin syringe
Doses per vial: 20 doses at 250 mcg, or 10 doses at 500 mcg
Selank can be administered subcutaneously (SubQ) or intranasally. For SubQ injection, follow standard peptide injection technique.
For intranasal use, transfer reconstituted Selank to a sterile nasal spray bottle. Each spray delivers approximately 0.1 mL. Administer 1–2 sprays per nostril per dose. Clear nasal passages before use. Tilt head slightly forward, insert tip into nostril, and spray while inhaling gently. Avoid blowing nose for 5 minutes after administration.
Selank benefits from its Pro-Gly-Pro extension, which provides better enzymatic stability than native tuftsin. Proper storage practices remain essential.
Selank has been well-tolerated in Russian clinical use since its approval in 2009, with a safety profile that compares favorably to benzodiazepines and SSRIs.
Selank is approved in Russia but is classified as a research peptide in most other jurisdictions. It's not FDA-approved for any clinical use. Everything here is from published research — it's not medical advice.
Selank is frequently studied alongside other nootropic peptides, particularly Semax. The two compounds have complementary mechanisms and are often combined in research protocols.
The most common nootropic peptide combination. Selank provides anxiolytic and mood-stabilizing effects while Semax delivers cognitive enhancement and neuroprotection. The two peptides share the same Pro-Gly-Pro stabilizing extension but act through different receptor systems.
| Peptide | Dose | Frequency | Duration |
|---|---|---|---|
| Selank | 250–500 mcg | 2x daily (intranasal) | 14–21 days |
| Semax | 200–600 mcg | 2–3x daily (intranasal) | 10–21 days |
Research suggests the following complementary practices may support Selank's anxiolytic and cognitive effects:
Selank is available in 5 mg vials from Heritage Labs USA, a U.S.-based research peptide supplier with batch-level purity verification.